Altos Labs is a biotechnology company developing therapies based on cellular rejuvenation programming, with the goal of restoring cell health and reversing aging-related disease, injury, and disabilities. The company operates institutes in the Bay Area, San Diego, and Cambridge, UK, each staffed by scientists and industry leaders working on fundamental problems in cell biology, aging biology, and regenerative medicine.
The company's scientific approach combines experimental work in stress-resistance assays and cell biology with computational methods. Altos Labs develops multi-scale generative models and applies machine learning to understand biological systems at multiple levels of organization. Early experimental work has demonstrated that cells can regain their ability to resist stressors associated with disease, suggesting that cellular dysfunction linked to aging may be reversible.
Altos Labs structures itself to merge elements of academic research with pharmaceutical development practices. The organization prioritizes both the freedom to pursue challenging biological problems and the patient-focused drive characteristic of successful drug development. This model brings together expertise across cellular rejuvenation programming, computational biology, systems biology, and translational drug development.
